The Discounted Cash Flow (DCF) valuation of Reata Pharmaceuticals Inc (RETA) is (232.26) USD. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on DCF is -234.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 9.0% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (413.77) - (165.14) | (232.26) |
| Upside | -340.1% - -195.8% | -234.8% |